Mercy Family Health announces a new treatment for peripheral neuropathy is available in DuBois, PA. Restorative Health Care ...

A new treatment for a debilitating genetic disease causing sudden sight loss is now available on the NHS in England. Evidence ...

Researchers have identified several modifiable risk factors that can help prevent the potentially life-threatening condition.

Vertex Pharmaceuticals is backed by CF dominance and JOURNAVX optionality, with key catalysts ahead for growth and upside.

Chronic pain is one of the most common and expensive health problems in the nation, affecting an estimated one in five U.S.

The global Neuromodulation Market , valued at US$6.26 billion in 2024, stood at US$6.81 billion in 2025 and is projected to ...

The NHS has issued a warning to anyone who takes statins on its website, as consuming one particular type of fruit 'could make things worse'. Statins remain the most commonly prescribed medication in ...

A treatment for a debilitating genetic disease that causes sudden sight loss is now available on the NHS in England. Evidence shows idebenone may improve eyesight in people with Leber Hereditary Optic ...

Presentations collectively highlight pilavapadin’s potential to improve pain management care for patients with diabetic peripheral neuropathic ...

The open-angle glaucoma market is projected to grow steadily, driven by the rising global prevalence of glaucoma due to aging populations and increasing awareness of early diagnosis. Additionally, the ...

Two head-to-head phase III trials demonstrated superior efficacy, including overall survival versus a daratumumab-based ...